MAPK3 and disease of the tendon: IRS1 and ERK-1/2 were once demonstrated to be activated in load-induced tenocyte in vivo under insulin-like growth factor 1 (IGF1) signaling during the pathogenesis of overused tendon disorders although no chondro-osteogenesis was observed (Scott et al., 2007).